【港股医药股多数走强 乐普生物涨超20%】截至发稿,乐普生物(02157.HK)涨22.09%、再鼎医药(09688.HK)涨14.59%、加科思-B(01167.HK)涨12.43%。消息面上,乐普生物自主研发的候选药物MRG003抗体药物偶联物候选药物,用于治疗复发性或转移性鼻咽癌的关键注册性IIb期研究结果,入选2025年美国临床肿瘤学会年会“重磅研究摘要”,并将于会上作口头报告。

金融界
28 Mar
截至发稿,乐普生物(02157.HK)涨22.09%、再鼎医药(09688.HK)涨14.59%、加科思-B(01167.HK)涨12.43%。消息面上,乐普生物自主研发的候选药物MRG003抗体药物偶联物候选药物,用于治疗复发性或转移性鼻咽癌的关键注册性IIb期研究结果,入选2025年美国临床肿瘤学会年会“重磅研究摘要”,并将于会上作口头报告。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10